Langdon Place of Keene
Keene, New Hampshire · CCN 305085
13 surveys since 2010, and no finding has been recorded at harm level.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
- Citations on record
- 39
- Surveys
- 13
- Harm or worse
- 0
- Immediate jeopardy
- 0
No finding on record has been cited at harm level or above.
Older surveys no longer in CMS’s monthly file or on Care Compare. They are shown here.
The facility
- Certified beds
- 25
- Ownership
- For profit - Limited Liability company
- Chain
- 603 HEALTHCARE
- County
- Cheshire · rural
- Medicare-certified since
- 1997
CMS ratings
- Overall
- 5
- Health inspection
- 5
- Staffing
- 5
- Quality measures
- 4
CMS’s own Five-Star ratings.
Compared with similar facilities
Not shown for this facility: too few citations in window (n=13, floor 20).
Last survey on record
Feb 11, 2026
271 days ago.
Counts surveys with at least one finding. A clean survey leaves no record here, so the real gap may be shorter.
Staffing
| Measure | This facility | Peer median |
|---|---|---|
| Nurse hours per resident day | 5.26 | 4.01 |
| Registered-nurse hours per resident day | 2.01 | — |
| Annual nurse turnover | 26.5% | 46.5% |
As reported by the facility to CMS, beside the peer-group median.
Enforcement
No fines, payment denials or special-focus designation on the current CMS record.
Severity of recent findings
| Severity | Isolated | Pattern | Widespread |
|---|---|---|---|
| Immediate jeopardy | J— | K— | L— |
| Actual harm | G— | H— | I— |
| No harm, potential for more than minimal | D6100.0% | E— | F— |
| No harm, potential for minimal | A— | B— | C— |
Most frequently cited here
In CMS’s current monthly file.
- F8803×
Provide and implement an infection prevention and control program.
- F6981×
Provide safe, appropriate dialysis care/services for a resident who requires such services.
- F7561×
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
- F7581×
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
In the surveyor’s words
From the most serious findings on record at Langdon Place of Keene, in the surveyor’s own words.
- No harm, potential for more than minimal, isolatedF880Feb 11, 2026
Based on observation, interview, and record review, the facility failed to implement water management control measures which could potentially expose the facility's census of 25 residents to the spread and growth of water borne pathogens. Findings include:Review on 2/10/26 of the facility's policy titled, Legionella Surveillance, revised on 9/1/25, revealed, .5. Primary Prevention Strategies:.d. Temperature controls: .ii. Hot water shall be stored above 140 [degrees] F [Fahrenheit] and circulated at a minimum return temperature of 124 F.Review on 2/10/26 of the facility water management plan, dated 11/18/25, revealed, .Area where Legionella Could Grow and Spread .Hot water holding tanks .Control Measures & [and] Corrective Action .Hot water holding tanks: .For both types of tanks check for… […]
- No harm, potential for more than minimal, isolatedF880Jan 3, 2025
Based on observation, interview, and record review, it was determined that the facility failed to implement policies and procedures for Enhanced Barrier Precautions (EBP) for 1 of 2 residents reviewed for EBP in a final sample of 13 residents. (Resident identifier is #176.) Findings include: Observation on 1/2/25 at approximately 10:00 a.m. on the unit revealed an EBP sign and Personnel Protective Equipment (PPE) cart outside of Resident #176's room next to the entrance door. Review on 1/2/25 of Resident #176's active physician's order revealed an order for a Peripherally Inserted Central Catheter (PICC) line with a start date of 1/2/25. Observation on 1/3/25 at approximately 6:00 a.m. […]
- No harm, potential for more than minimal, isolatedF698Jan 18, 2024
Based on interview and record review, it was determined that the facility failed to ensure that a resident receiving dialysis services received medications according to physician orders and failed to ensure monitoring of a dialysis fistula site for 1 of 1 resident reviewed for dialysis in a final sample of 12 residents (Resident Identifier is #11). Findings include: Review on 1/17/24 of Resident #11's January 2024 Medication Administration Record (MAR) revealed the following physician's order: Hydralazine HCL [Hydrochloric Acid] oral tablet 100 mg [milligrams] give 1 tablet by mouth three times a day for Hypertension, start date 12/28/23. Review revealed that the times for administration were 8:00 a.m., 2:00 p.m., and 8:00 p.m. […]
- No harm, potential for more than minimal, isolatedF756Jan 18, 2024
Based on interview and record review, it was determined that the pharmacist failed to report irregularities to the facility for 2 out of 7 residents reviewed for drug regimen review in a final sample of 12 residents (Resident Identifiers are #7 and #14). Findings include: Resident #7 Review on 1/17/24 of Resident #7's January 2024 Medication Administration Record (MAR) revealed the following order: Lorazepam oral tablet 0.5 mg [milligrams] give 0.5 mg by mouth every 6 hours as PRN [as needed] for Anxiety, start date 11/27/23. Review on 1/17/24 of Resident #7's medical record revealed that the pharmacist completed Drug Regimen Reviews on 1/17/24, 12/11/23, and 11/27/23 and failed to identify the above PRN psychotropic medication did not have a stop date indicated. […]
- No harm, potential for more than minimal, isolatedF758Jan 18, 2024
Based on interview and record review, it was determined that the facility failed to ensure that orders for psychotropic drugs were limited to 14 days and that consents were obtained for the use of psychotropic medications for 2 of 2 residents reviewed for psychotropic/opioid side effects in a final sample of 12 residents reviewed (Resident Identifiers are #7 and #14). Findings include: Resident #7 Review on 1/17/24 of Resident #7's January 2024 Medication Administration Record (MAR) revealed the following order: Lorazepam oral tablet 0.5 mg [milligrams] give 0.5 mg by mouth every 6 hours PRN [as needed] for Anxiety, start date 11/27/23. […]
Read 20 findings in full →The most serious and the most recent: 20 of 39 on record.
Every survey on record
FindingsAt actual harm or above
- Feb 11, 2026Standard1 finding
- Jan 3, 2025Standard1 finding
- Jan 18, 2024Standard4 findings
- Jan 12, 2023Standard7 findings
- May 19, 2020Infection control1 finding
- Mar 5, 2020Standard2 findings
- Jan 2, 2018Standard2 findings
- Oct 4, 2016Standard2 findings
Show the 5 earlier surveys
- Oct 22, 2015Standard2 findings
- Dec 17, 2014Standard4 findings
- Nov 6, 2013—1 finding
- Dec 14, 2011—2 findings
- Sep 22, 2010—10 findings
Surveys that found no deficiencies are not in CMS’s files and do not appear here.
Comparable facilities
The nearest facilities to this one in the same peer group, by weighted findings.
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction